Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Apr;35(4):e14245.
doi: 10.1111/ctr.14245. Epub 2021 Feb 17.

Bamlanivimab for treatment of COVID-19 in solid organ transplant recipients: Early single-center experience

Abhay Dhand  1 , Stephen A Lobo  1 , Kevin Wolfe  2 , Nicholas Feola  3 , Christopher Nabors  1
Affiliations

Bamlanivimab for treatment of COVID-19 in solid organ transplant recipients: Early single-center experience

Abhay Dhand et al. Clin Transplant. 2021 Apr.
No abstract available

PubMed Disclaimer

Conflict of interest statement

AD, SL: received institutional research grant from Regeneron. All other authors of this manuscript have no conflicts of interest to disclose as described by the Clinical Transplantation.

Comment in

References

    1. Pereira MR, Mohan S, Cohen DJ, et al. COVID‐19 in solid organ transplant recipients: Initial report from the US Epicenter. Am J Transplant. 2020;20:1800‐1808. 10.1111/ajt.15941 - DOI - PMC - PubMed
    1. Kates OS, Haydel BM, Florman SS, et al. COVID‐19 in solid organ transplant: a multi‐center cohort study. Clin Infect Dis. 2020;ciaa1097: 10.1093/cid/ciaa1097 - DOI
    1. Food and Drug Administration . Fact sheet for healthcare providers: emergency use authorization (EUA) of bamlanivimab; 2020. https://www.fda.gov/media/143603/download. Accessed November 14, 2020
    1. Chen P, Nirula A, Heller B, et al. SARS‐CoV‐2 neutralizing antibody LY‐CoV555 in outpatients with COVID‐19. N Engl J Med. 2021;384(3):229‐237. - PMC - PubMed
    1. Lundgren JD, Grund B, Barkauskas CE, et al. A Neutralizing Monoclonal Antibody for Hospitalized Patients with Covid‐19. New England Journal of Medicine. 2020. 10.1056/nejmoa2033130. - DOI - PMC - PubMed

Substances